Viewing Study NCT02643420

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-25 @ 4:19 AM

Ignite Modification Date: 2026-01-21 @ 9:44 PM

Study NCT ID: NCT02643420

Status: COMPLETED

Last Update Posted: 2022-03-02

First Post: 2015-12-29

Is Gene Therapy: True

Has Adverse Events: True

Brief Title: SPI-2012 vs Pegfilgrastim in the Management of Neutropenia in Participants With Breast Cancer With Docetaxel and Cyclophosphamide (ADVANCE)

Sponsor: Spectrum Pharmaceuticals, Inc

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module Adverse Events Module Baseline Characteristics Module Participant Flow Module